KA
ABBV icon

Kercheville Advisors’s AbbVie ABBV Stock Holding History

Kercheville Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Sell
1,415
-48
-3% -$10.6K 0.1% 84
2025
Q4 		$319K Buy
1,463
+1
+0.1% +$228 0.08% 91
2025
Q3 		$339K Buy
1,462
+39
+3% +$7.94K 0.1% 82
2025
Q2 		$264K Buy
1,423
+202
+17% +$37.5K 0.09% 83
2025
Q1 		$256K Hold
1,221
– – 0.1% 73
2024
Q4 		$217K Buy
+1,221
New +$224K 0.08% 81
2024
Q2 		– Sell
-6,900
Closed -$1.26M – 85
2024
Q1 		$1.26M Buy
+6,900
New +$1.19M 0.59% 36
2022
Q2 		– Sell
-6,570
Closed -$1.06M – 95
2022
Q1 		$1.06M Sell
6,570
-900
-12% -$131K 0.5% 43
2021
Q4 		$1.01M Buy
+7,470
New +$882K 0.44% 47

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kercheville Advisors's ABBV Position: Q1 2026 in Review

Kercheville Advisors reduced its AbbVie (ABBV) stake by 3.3% in Q1 2026, selling an estimated $10.6K and leaving 1,415 shares worth $308K. The position accounts for 0.1% of the portfolio, ranked #84.

Kercheville Advisors first reported a position in ABBV in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.26M in Q1 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Kercheville Advisors held 1,415 shares of AbbVie worth $308K as of Q1 2026.
  • Kercheville Advisors sold 48 AbbVie shares in Q1 2026, an estimated $10.6K.
  • AbbVie made up 0.1% of Kercheville Advisors's portfolio in Q1 2026, its #84 holding.
  • Kercheville Advisors first reported a position in AbbVie in Q4 2021 and has held it in 9 quarters since.
  • Kercheville Advisors's AbbVie position peaked at $1.26M in Q1 2024.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kercheville Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.